Skip to main content

Table 5 Focal cryosurgery outcomes

From: Focal cryosurgical ablation of the prostate: a single institute’s perspective

Authors, dates

No. of pts

Follow-up years

Biochemical failure definition

Biochemical disease -free survival

Biopsy proven ipsilateral disease

Potency

Continence

Voiding symptoms

Lambert et al., 2007[11]

25

2.3 (median)

ASTRO criteria

84% (PSA Nadir >50%)

4%

71%

100%

N/A

Ellis et al., 2007[12]

60

1.3 (mean)

ASTRO criteria

80% (ASTRO)

1.7%

70.6% @ 1yr

96.4%

N/A

Onik et al., 2008[7]

48

4.5 (mean)

ASTRO criteria

94% (ASTRO)

0%

90%

100%

N/A

Truesdale et al., 2010[13]

77

2 (median)

Phoenix criteria

73%

4%

N/A

N/A

N/A

Ward et al., 2012[14]

1160

1.8 (mean)

ASTRO criteria

75.7% (ASTRO) @ 3yr

3.7% (Unsure Laterality)

58.1%

98.4%

1.1%^

Bahn et al., 2012[2]

73

3.7 (median)

ASTRO criteria

N/A

1%

86%

100%

N/A

Present Study

26

1.6 (mean)

0.5 ng/ml over nadir[8]

88%

0%

73%*

100%

4%^

  1. ASTRO criteria, 3 consecutive rises in the serum PSA after the post-radiation PSA nadir; Phoenix criteria, serum PSA nadir post-radiation + 2 ng/ml.
  2. *, Remainder 27% potent with the use of pharmacologic or mechanical aids.
  3. ^, urinary retention.